Zdrowie i gospodarka · 13/06/1997

FDA Revises Submission Schedule for Class III Devices

The FDA is revising the submission schedule for 31 class III devices, including cardiovascular devices, to facilitate the review process. Manufacturers must submit summaries and citations by February 14, 1998, for the grouped devices and by their original due dates for other devices.